CANDIDATE | FORMAT | INDICATION | RESEARCH | LEAD OPTIMIZATION | IND-ENABLING | CLINICAL DEVELOPMENT |
| FBT-NuNi | MDM2 inhibitor (small molecule) | Dry AMD |  | |||
| FBT-SP101 | ROS inducer (small molecule) | Multiple diseases | | |||
| FBT-SP201 | ROS inducer (small molecule) | Multiple diseases | |
CANDIDATE | FORMAT | INDICATION | RESEARCH | LEAD OPTIMIZATION | IND-ENABLING | CLINICAL DEVELOPMENT |
| FBT-VR(HR) | VEGFR2 targeting recombinant protein-prolonged | Wet AMD | |
CANDIDATE | FORMAT | INDICATION | RESEARCH | LEAD OPTIMIZATION | IND-ENABLING | CLINICAL DEVELOPMENT |
| FBT-HR2-ProNP | (Recombinant protein + chemical combined) | Cancer | | |||
| FBT-ER-ProNP | (Recombinant protein + chemical combined) | Cancer | |
